MTNB icon

Matinas BioPharma
MTNB

Overview Fund Trends Analyst Outlook Journalist POV

42 hedge funds and large institutions have $6.91M invested in Matinas BioPharma in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$152K
2
+$35.1K
3
+$18.5K
4
SW
Simplicity Wealth
New Jersey
+$16.3K
5
UBS Group
UBS Group
Switzerland
+$12.2K

Top Sellers

1
-$68.7K
2
-$56.2K
3
-$35K
4
Wells Fargo
Wells Fargo
California
-$33.9K
5
BCM
Bridgeway Capital Management
Texas
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11.3K
27
$7.91K
28
$7.48K
29
$7.18K
30
$5.46K
31
$5.07K
32
$4.74K
33
$3.25K
34
$3K
35
$2.91K
36
$2.71K
37
$2.7K
38
$1.35K
39
$824
40
$557
41
$179
42
$174
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3